Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

about

Lipo-DUE1 Lipo246

P1343

Q54902549-38C56F59-3DA1-42A7-B48F-79AA28760D98 Q54902553-09AEB8B2-FE1E-4BC3-B621-C7A44FE9C584

P1343

Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

Item

http://www.wikidata.org/entity/Q38835065

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Peritoneal sarcomatosis: site ...... dedifferentiated liposarcoma.

@en

type

Item

label

Peritoneal sarcomatosis: site ...... dedifferentiated liposarcoma.

@en

prefLabel

Peritoneal sarcomatosis: site ...... dedifferentiated liposarcoma.

@en

P1476

Peritoneal sarcomatosis: site ...... dedifferentiated liposarcoma.

@en

P2093

Andreas Krieg

http://www.w3.org/2001/XMLSchema#string

Birte Möhlendick

http://www.w3.org/2001/XMLSchema#string

Hany Ashmawy

http://www.w3.org/2001/XMLSchema#string

Helmut E Gabbert

http://www.w3.org/2001/XMLSchema#string

Jasmin C Riemer

http://www.w3.org/2001/XMLSchema#string

Markus P Ghadimi

http://www.w3.org/2001/XMLSchema#string

Nikolas H Stoecklein

http://www.w3.org/2001/XMLSchema#string

Philipp M Schlünder

http://www.w3.org/2001/XMLSchema#string

Sabrina Mersch

http://www.w3.org/2001/XMLSchema#string

Stefan A Topp

http://www.w3.org/2001/XMLSchema#string

P2860

Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.

Liposarcoma: new entities and evolving concepts.

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.

Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review.

Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.

An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.

New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.

Characterization of liposarcoma cell lines for preclinical and biological studies.

Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.

P2888

s13277-015-4050-6

P304

2341-2351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4050-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P4510

Lipo-DUE1

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patric Kröpil

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036179734

http://www.w3.org/2001/XMLSchema#string

P698

26373732

http://www.w3.org/2001/XMLSchema#string

P921

cell line

Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

about

P1343

P1343

Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P4510

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P4510

P478

P50

P577

P6179

P698

P921